Synthesis and antimicrobial activities of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines carrying thioalkyl and sulphonyl phenoxy moieties

European Journal of Medicinal Chemistry

Volumn 42, Issue 4, 2007, Pages 521-529

  Karabasanagouda, T ^a   Adhikari, Airody Vasudeva ^b   Shetty, N Suchetha ^c  

^a Strides Research and Specialty Chemicals Ltd   (India)

^b NATIONAL INSTITUTE OF TECHNOLOGY KARNATAKA   (India)

^c NITTE DEEMED TO BE UNIVERSITY   (India)

Author keywords

6 Aryl 3 (4 methyl sulphonyl phenoxy) methyl 1,2,4 triazolo 3,4 b 1,3,4 thiadiazines; 6 Aryl 3 (4 methyl sulphonyl phenoxy) methyl 1,2,4 triazolo 3,4 b 1,3,4 thiadiazoles; 6 Aryl 3 (4 thio alkyl phenoxy) methyl 1,2,4 triazolo 3,4 b 1,3,4 thiadiazoles; 6 Aryl 3 (4 thioalkyl phenoxy) methyl 1,2,4 triazolo 3,4 b 1,3,4 thiadiazines; Antibacterial and antifungal screening

Indexed keywords

1,2,4 TRIAZOLO[3,4 B] 1,3,4 THIADIAZINE; 1,2,4 TRIAZOLO[3,4 B] 1,3,4 THIADIZOLE; 1,3,4 THIADIAZINE DERIVATIVE; 1,3,4 THIADIAZOLE DERIVATIVE; 2 [4 METHYLSULFONYLPHENOXY]ACETOHYDRAZIDE; 2 [4 THIOPHENOXY]ACETOHYDRAZIDE DERIVATIVE; 3 [(4 METHYLSULFONYLPHENOXY)METHYL] 1,2,4 TRIAZOLO[3,4 B] 1,3,4 THIADIAZINE; 3 [(4 METHYLSULFONYLPHENOXY)METHYL] 1,2,4 TRIAZOLO[3,4 B] 1,3,4 THIADIAZOLE; 3 [(4 THIOPHENOXY)METHYL] 1,2,4 TRIAZOLO[3,4 B] 1,3,4 THIADIAZINE; 3 [(4 THIOPHENOXYL)METHYL] 1,2,4 TRIAZOLO[3,4 B] 1,3,4 THIADIAZOLE; 4 AMINO 5 [(4 METHYLSULFONYLPHENOXY)METHYL] 4H 1,2,4 TRIAZOLE 3 THIOL; 4 AMINO 5 [(4 THIOPHENOXY)METHYL] 4H 1,2,4 TRIAZOLE 3 THIOL DERIVATIVE; 4 BROMOPHENACYL BROMIDE; [4 (METHYLSULFONYL)PHENOXY]ACETATE; ACETIC ACID; ACETONE; AROMATIC CARBOXYLIC ACID; CARBON DISULFIDE; CHLOROACETIC ACID; ETHYL (4 THIOPHENOXYL)ACETATE DERIVATIVE; HYDRAZINE; HYDROGEN PEROXIDE; PHENOL DERIVATIVE; POTASSIUM CARBONATE; POTASSIUM DITHIOCARBAZATE DERIVATIVE; POTASSIUM HYDROXIDE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIA; FUNGI; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; THIADIAZINES; THIADIAZOLES;

EID: 34047221878     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2006.10.010     Document Type: Article

References (24)

1. Goswami B.N., Kataky J.C.S., and Baruah J.N. J. Heterocycl. Chem. 21 (1984) 1225
2. Khan R.H., Srivastava R.A.K., and Rastogi R.C. Indian J. Chem. 24B (1985) 883
3. Heeres J., and Backx L.J. J. Med. Chem. 27 (1984) 894
4. Mullican M.D., Wilson M.W., Connor D.T., Kostlan C.R., Schrier d.J., and Dyer R.D. J. Med. Chem. 36 (1993) 1090
5. Czarnocka A., Janowicz, Foks H., Nasal A., Petrusewicz J., Damasiewicz B., Radwanska A., and Kaliszan R. Pharmazie 46 (1991) 109
6. Sidwell R.W., Allen L.B., Hoffman J.H., Witkowshi J.T., and Simon L.N. Proc. Soc. Exp. Biol. Med. 148 (1975) 854
7. Chem. Abstr. 118 (1993) 11961z
8. Singh K., Hasan A., Pratap R., Guru P.Y., and Bhakuni D.S. J. Indian Chem. Soc. 66 (1989) 686
9. Hart C. Drugs for migraine. Modern Drug Discovery (1999), American Chemical Society
10. M.E. Deason, K.R. Whitten, US 5,962,725, Oct. 5, 1999.
11. A.S. Bell, D. Brown, N.K. Terrett, US 5,250,534, Oct. 5, 1993.
12. A.L. Rawlins, G.P. Woods, US 2,589,211, March 18, 1952.
13. J.M. Sprague, D.H. Pa, US 2,407,966, Sept. 17, 1946.
14. B. Camerino, G.P. Milan, US 3,098,069, July 16, 1963.
15. D.H. Boschelli, D.T. Connor, C.R. Kostlan, J.B. Kramer, M.D. Mullican, J.C. Sircar, US 5,102,897, April 7, 1992.
16. Farghaly A.R., Clercq E.D., and El-Kashef H. ARKIVOC 10 (2006) 137
17. Zhang Z.Y., Li M., Zhao L., Li Z.M., and Liao R.A. Chin. J. Org. Chem. 13 (1993) 397
18. Gupta R., Sudan S., Mengi V., and Kachroo P.L. Indian J. Chem., Sect. B 35 (1996) 621
19. Barry A.L. Procedure for testing antimicrobial agents in agar media. In: Corian V.L. (Ed). Antibiotics in Laboratory Medicine (1991), Williams and Wilkins, Baltimore, MD 1
20. James D., Lowry Mac., Jaqua M.J., and Selepak S.T. Appl. Microbiol. 20 (1970) 46
21. Arthington-Skaggs B.A., Motley M., Warnock D.W., and Morrison C.J. J. Clin. Microbiol. 38 (2000) 2254
22. In: Verma R.S., Khan Z.K., and Singh A.P. (Eds). Antifungal Agents: Past, Present and Future Prospects (1998), National Academy of Chemistry and Biology, Lucknow, India p. 55
23. Fenlon C.H., and Cynamon M.H. Antimicrob. Agents Chemother. 29 (1986) 386
24. Davis R., Markham A., and Balfour J.A. Ciprofloxacin, An updated review of its pharmacology, therapeutic efficacy and tolerability, Drugs 51 6 (1996) 1019